Gritstone bio, Inc.

OTCPK:GRTS.Q Stok Raporu

Piyasa değeri: US$2.3m

Gritstone bio Yönetim

Yönetim kriter kontrolleri 2/4

Gritstone bio CEO'su Andrew Allen, Aug2015 tarihinde atandı, in görev süresi 9.17 yıldır. in toplam yıllık tazminatı $ 3.44M olup, şirket hissesi ve opsiyonları dahil olmak üzere 18.8% maaş ve 81.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.53% ine doğrudan sahiptir ve bu hisseler $ 34.96K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.6 yıl ve 6.4 yıldır.

Anahtar bilgiler

Andrew Allen

İcra Kurulu Başkanı

US$3.4m

Toplam tazminat

CEO maaş yüzdesi18.8%
CEO görev süresi9.2yrs
CEO sahipliği1.5%
Yönetim ortalama görev süresi3.6yrs
Yönetim Kurulu ortalama görev süresi6.4yrs

Son yönetim güncellemeleri

We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Jun 11
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Recent updates

We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Jun 11
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering

Apr 07

Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%

Aug 14
Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%

Gritstone bio: Early Data For SLATE Candidate Sets Up 2023 Catalyst

Sep 26

Gritstone reaches six-month high on publication of data for cancer vaccine

Aug 16

Gritstone bio announces $80M credit facility

Jul 21

Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?

Jul 07
Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?

Gritstone bio: Potential To Advance Colorectal Cancer Treatment

Jul 05

Gritstone bio: Investing In A Premium mRNA Technology At A Discounted Valuation

Jun 14

Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates

Mar 17
Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates

We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate

Mar 05
We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate

Gritstone: Why The Stock Fell On Positive Data

Jan 18

Gritstone bio (NASDAQ:GRTS) Is In A Strong Position To Grow Its Business

Nov 23
Gritstone bio (NASDAQ:GRTS) Is In A Strong Position To Grow Its Business

CEO Tazminat Analizi

Andrew Allen'un ücretlendirmesi Gritstone bio'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$133m

Mar 31 2024n/an/a

-US$145m

Dec 31 2023US$3mUS$646k

-US$138m

Sep 30 2023n/an/a

-US$139m

Jun 30 2023n/an/a

-US$130m

Mar 31 2023n/an/a

-US$125m

Dec 31 2022US$3mUS$620k

-US$120m

Sep 30 2022n/an/a

-US$118m

Jun 30 2022n/an/a

-US$116m

Mar 31 2022n/an/a

-US$112m

Dec 31 2021US$4mUS$589k

-US$75m

Sep 30 2021n/an/a

-US$72m

Jun 30 2021n/an/a

-US$70m

Mar 31 2021n/an/a

-US$71m

Dec 31 2020US$2mUS$569k

-US$105m

Sep 30 2020n/an/a

-US$106m

Jun 30 2020n/an/a

-US$107m

Mar 31 2020n/an/a

-US$103m

Dec 31 2019US$2mUS$533k

-US$94m

Sep 30 2019n/an/a

-US$84m

Jun 30 2019n/an/a

-US$75m

Mar 31 2019n/an/a

-US$69m

Dec 31 2018US$2mUS$475k

-US$65m

Sep 30 2018n/an/a

-US$65m

Jun 30 2018n/an/a

-US$56m

Mar 31 2018n/an/a

-US$47m

Dec 31 2017US$592kUS$436k

-US$41m

Tazminat ve Piyasa: Andrew 'nin toplam tazminatı ($USD 3.44M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 650.00K ).

Tazminat ve Kazançlar: Andrew şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Andrew Allen (58 yo)

9.2yrs

Görev süresi

US$3,444,071

Tazminat

Dr. Andrew R. Allen, BM, BCh, MA, MRCP, M.D., Ph D., serves as Independent Director at Verge Analytics, Inc. since September 2021. He has also held clinical development leadership positions at Chiron Corpo...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Andrew Allen
Co-Founder9.2yrsUS$3.44m1.53%
$ 35.0k
Erin Jones
Executive VP & COO3.6yrsUS$1.52m0.063%
$ 1.4k
Karin Jooss
Executive VP and Head of Research & Development3.6yrsUS$1.58m0.39%
$ 8.9k
Vassiliki Economides
Executive VP & CFO3.3yrsVeri yok0.059%
$ 1.3k
James Cho
Chief Accounting Officer3.8yrsVeri yok0.070%
$ 1.6k
George MacDougall
Director of Investor Relations & Corporate Communicationsno dataVeri yokVeri yok
Stacy Proctor
Executive VP & Chief People Officer3.3yrsVeri yokVeri yok
Matthew Hawryluk
Executive VP & Chief Business Officer8.9yrsVeri yok0.034%
$ 776.2

3.6yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim: GRTS.Q 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.6 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Andrew Allen
Co-Founder9.2yrsUS$3.44m1.53%
$ 35.0k
Elaine Jones
Independent Chairman of the Board5.1yrsUS$176.00k0%
$ 0
Stephen Webster
Independent Directorless than a yearVeri yok0.021%
$ 482.6
Lawrence Corey
Independent Director2.2yrsUS$132.50k0%
$ 0
Timothy Chan
Member of Scientific Advisory Board7.3yrsVeri yokVeri yok
Eugene Zhukovsky
Member of Scientific Advisory Board5.5yrsVeri yok0%
$ 0
Graham Lord
Member of Scientific Advisory Board7.3yrsVeri yokVeri yok
Naiyer Rizvi
Independent Director & Member of Scientific Advisory Board8.3yrsUS$140.00k0%
$ 0
James Gulley
Member of Scientific Advisory Board7.3yrsVeri yokVeri yok
Alessandro Sette
Member of Scientific Advisory Board7.3yrsVeri yokVeri yok
Shefali Agarwal
Independent Director3.3yrsUS$138.50k0%
$ 0
Clare Fisher
Independent Director2.8yrsUS$136.50kVeri yok

6.4yrs

Ortalama Görev Süresi

61.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: GRTS.Q 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.4 yıldır).